A Study of LY2951742 in Healthy Japanese and Caucasian Participants

Exclusion Criteria

• •Participants are heavy caffeine drinkers defined by regular intake of more than 5 cups of coffee (or equivalent in xanthine containing beverages) per day, and/or are unable or unwilling to abide by caffeine restrictions as specified in the protocol.
• •Participants are smoking within the previous 6 months.
• •Participants have received treatment with biologic agents (such as monoclonal antibodies) within 3 months or 5 half-lives (whichever is longer) prior to dosing or have received a vaccination within 1 month.
• •Participants have known allergies to LY2951742, related compounds or any components of the formulation, or history of significant atopy.
• •Participants are allergies to either humanized monoclonal antibodies, diphenhydramine, epinephrine, or methylprednisolone.